GlaxoSmithKline, Amfar Form Pact To Optimize HIV Treatment In Asia

17th Jun 2010 14:09

LONDON (Dow Jones)--Pharmaceutical giant GlaxoSmithKline PLC (GSK) and amfAR Thursday announce a two year partnership that aims to improve access and optimize the quality of healthcare for infants and children living with HIV across Asia. MAIN FACTS: -$2 million initiative created to generate clinical evidence and develop strategies to support life-long paediatric care and help inform global treatment guidelines. -GlaxoSmithKline shares at 1205 GMT down 9 pence, or 0.7%, at 1215 pence valuing the company at GBP63.09 billion. -By Ian Walker, Dow Jones Newswires; 44-20-7842-9296; [email protected] (END) Dow Jones Newswires June 17, 2010 09:09 ET (13:09 GMT)

Top Risers

Share	Price	Change
Huddled Group (HUD)	0.85	24.14%
Eurasia Mining (EUA)	2.80	19.15%
Genincode (GENI)	0.725	16%
Medpal AI (MPAL)	5.25	14.13%
Light Science Technologies (LST)	0.875	12.9%

Top Fallers

Share	Price	Change
Catenai Plc (CTAI)	0.0575	-39.47%
Petra Diamonds (PDL)	2.60	-26.14%
Focus Xplore (FOX)	0.019	-22.45%
Litigation Cap. (LIT)	0.301	-20.12%
Abrdn Property (API)	1.52	-15.56%

Top By Volume

Share	Price	Volume
Ethernity Net (ENET)	0.0019	1,922,336,250
Forgent (FORG)	0.0115	591,087,829
Premier African Minerals (PREM)	0.0044	313,776,718
Focus Xplore (FOX)	0.019	253,421,870
Bezant Resources PLC (BZT)	0.11	246,929,868

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.